So...I was actually thinking that the company is v
Post# of 36537
(Total Views: 403)
Posted On: 06/27/2020 1:12:18 PM
So...I was actually thinking that the company is valuing ngio at more than $1 billion because with 400 million shares outstanding, and not wanting to start PPS at too close to $2...I am guessing at least $3-$4 to start...so that’s $1.2 to $1.6 billion...I guess it make sense if ngio is acquiring another company...and increasing value of ngio...
Also, I am wondering if there are already companies expressing interest in possibly buying ngio...the reason why I said that is because we have not heard any word on receiving funding from CEPI/BARDA/health Canada/Malaysia...yet Gnbt just entered into a contract to test peptides against infected blood for $1 million...they seem to be confident that funds will be forthcoming somehow...so my speculation is ngio has garnered much interest for either private funding or potential takeover...
Now back to the $15 Gnbt PPS that warrant is offering...it starting to look more and more reasonable
What do you guys think?
Also, I am wondering if there are already companies expressing interest in possibly buying ngio...the reason why I said that is because we have not heard any word on receiving funding from CEPI/BARDA/health Canada/Malaysia...yet Gnbt just entered into a contract to test peptides against infected blood for $1 million...they seem to be confident that funds will be forthcoming somehow...so my speculation is ngio has garnered much interest for either private funding or potential takeover...
Now back to the $15 Gnbt PPS that warrant is offering...it starting to look more and more reasonable
What do you guys think?
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼